Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Knocking out alpha-synuclein in melanoma cells dysregulates cellular iron metabolism and suppresses tumor growth
Sahar Shekoohi, Santhanasabapathy Rajasekaran, Dhaval S. Patel, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Iron homeostasis imbalance and ferroptosis in brain diseases
Haining Long, Wangshu Zhu, Liming Wei, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 45
Expanding our understanding of synucleinopathies: proteinopathy, proteinopenia, and lipidopathy
Manuel Flores‐León, Tiago F. Outeiro
FEBS Journal (2025)
Open Access | Times Cited: 2
Linking Parkinson's Disease and Melanoma: Interplay Between α‐Synuclein and Pmel17 Amyloid Formation
Dexter N. Dean, Jennifer C. Lee
Movement Disorders (2021) Vol. 36, Iss. 7, pp. 1489-1498
Open Access | Times Cited: 36
Knocking out alpha-synuclein in melanoma cells downregulates L1CAM and decreases motility
Nithya Gajendran, Santhanasabapathy Rajasekaran, Stephan N. Witt
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Uncovering potential diagnostic and pathophysiological roles of α‐synuclein and DJ‐1 in melanoma
Agathe Quesnel, Leya Danielle Martin, Chaimaa Tarzi, et al.
Cancer Medicine (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Alpha-synuclein regulates nucleolar DNA double-strand break repair in melanoma
Moriah R. Arnold, Gabriel Cohn, Kezia Catharina Oxe, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Transcriptomic analysis of melanoma cells reveals an association of α-synuclein with regulation of the inflammatory response
Santhanasabapathy Rajasekaran, Siyuan Cheng, Nithya Gajendran, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Identification and validation of five ferroptosis-related molecular signatures in keloids based on multiple transcriptome data analysis
Zhen Sun, Yonghong Qin, Xuanfen Zhang
Frontiers in Molecular Biosciences (2025) Vol. 11
Open Access
Alpha-synuclein knockout impairs melanoma development and alters DNA damage repair in the TG3 mouse model in a sex-dependent manner
Moriah R. Arnold, Suzie Chen, Vivek K. Unni
Frontiers in Oncology (2025) Vol. 15
Open Access
Distinct molecular mechanisms contribute to the reduction of melanoma growth and tumor pain after systemic and local depletion of alpha‐Synuclein in mice
Ellen Niederberger, Moritz Möller, Eleonora Mungo, et al.
The FASEB Journal (2023) Vol. 37, Iss. 12
Open Access | Times Cited: 10
Nuclear Alpha‐Synuclein in Parkinson’s Disease and the Malignant Transformation in Melanoma
María E. Jiménez‐Capdeville, Érika Chi-Ahumada, Francisco García-Ortega, et al.
Neurology Research International (2025) Vol. 2025, Iss. 1
Open Access
Bioinformatic analysis of ferroptosis related biomarkers and potential therapeutic targets in vitiligo
Linli Liu, Lingli Deng, Li Guan, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Alpha-synuclein regulates nucleolar DNA double-strand break repair in melanoma
Moriah R. Arnold, Gabriel Cohn, Kezia Catharina Oxe, et al.
Science Advances (2025) Vol. 11, Iss. 15
Open Access
Parkinson’s Disease Dementia: Synergistic Effects of Alpha-Synuclein, Tau, Beta-Amyloid, and Iron
Jiajun Han, Yaohua Fan, Peipei Wu, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 21
Genome editing and cancer: How far has research moved forward on CRISPR/Cas9?
Saikat Mitra, Joyatry Sarker, Anik Mojumder, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 113011-113011
Open Access | Times Cited: 15
Glial Cultures Differentiated from iPSCs of Patients with PARK2-Associated Parkinson’s Disease Demonstrate a Pro-Inflammatory Shift and Reduced Response to TNFα Stimulation
Tatiana Gerasimova, Ekaterina Stepanenko, Lyudmila Novosadova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2000-2000
Open Access | Times Cited: 9
Preclinical-to-Clinical Anti-Cancer Drug Response Prediction and Biomarker Identification Using TINDL
David Earl Hostallero, Lixuan Wei, Liewei Wang, et al.
Genomics Proteomics & Bioinformatics (2023) Vol. 21, Iss. 3, pp. 535-550
Open Access | Times Cited: 9
Possible regulation of the immune modulator tetraspanin CD81 by alpha-synuclein in melanoma
Nirjhar M. Aloy, Christina Coughlan, Michael W. Graner, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 734, pp. 150631-150631
Open Access | Times Cited: 3
SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma
Xiuao Zhang, Zhengcun Wu, Kaili Ma
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Synthesis and Preliminary Characterization of Putative Anle138b-Centered PROTACs against α-Synuclein Aggregation
Martina Pedrini, Angelo Iannielli, Lorenzo Meneghelli, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1467-1467
Open Access | Times Cited: 8
Synuclein Proteins in Cancer Development and Progression
Lucia Zanotti, Florencia Malizia, Nahuel Cesatti Laluce, et al.
Biomolecules (2023) Vol. 13, Iss. 6, pp. 980-980
Open Access | Times Cited: 7
Genome Editing Approaches with CRISPR/Cas9 for Cancer Treatment: Critical Appraisal of Preclinical and Clinical Utility, Challenges, and Future Research
Sergiu Chira, Andreea Nuțu, Ecaterina Isacescu, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2781-2781
Open Access | Times Cited: 12
Association between Parkinson’s Disease and Cancer: New Findings and Possible Mediators
Andrei Surguchov, Alexei Surguchev
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3899-3899
Open Access | Times Cited: 2
Insights into Dysregulated Neurological Biomarkers in Cancer
Elisa Duranti, Chiara Villa
Cancers (2024) Vol. 16, Iss. 15, pp. 2680-2680
Open Access | Times Cited: 2
alpha-synuclein, autophagy-lysosomal pathway, and Lewy bodies: mutations, propagation, aggregation, and the formation of inclusions
Armin Bayati, Peter S. McPherson
Journal of Biological Chemistry (2024) Vol. 300, Iss. 10, pp. 107742-107742
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top